BACE1 and Alzheimer disease: Another study by Nan et al. [163] demonstrated that EGCG can reduce the hyperphosphorylation of tau proteins, downregulate BACE1 and Aβ1-42 expression, and improve the antioxidant capacity, learning, and memory functions in AD rats.